Form 4 Tracker
Machelle Sanders

Director · 3 filings · Latest: Aug 3, 2026

BIOCRYST PHARMACEUTICALS INC
Fortrea Holdings Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
FTRE
Machelle SandersDirectorAug 3, 2026
Sale
$18.019,700$174.7K36,399
FTRE
SANDERS MACHELLE—Aug 3, 2026
Proposed Sale
$18.019,700$174.7K—
FTRE
Machelle SandersDirectorJun 10, 2026
Option Exercise
$0.0038,817—46,099
BCRX
SANDERS MACHELLE—Nov 13, 2025
Proposed Sale
$7.149,600$68.5K—